Hikma CEO takes the fall for cutting guidance

HIKMA PHARMACEUTICALS (HIK) – Healthcare Price: £14.95 -1.4% P/E: 10.5x Market Cap: £4.45bn Yield: 4% A month after the firm lowered its outlook, Hikma chief executive Riad Mishlawi is out the door and chairman Said Darwazah is stepping back in while the company looks for a new candidate. Group guidance remains unchanged from the 6 … Continue reading Hikma CEO takes the fall for cutting guidance